Multiple Sclerosis: Basic Concepts and Hypothesis

Mayo Clinic Proceedings

Volumn 64, Issue 5, 1989, Pages 570-576

  RODRIGUEZ, MOSES ^a  

^a Department of Immunology ^*

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; SYMPOSIUM;

EID: 0024354983     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)65563-3     Document Type: Article

References (70)

1. The neuropathology of multiple sclerosis
2. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis
3. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
4. Multiple sclerosis: distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages
5. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis
6. Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions
7. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
8. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development
9. Immunogenetics of multiple sclerosis
10. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression
11. HLA family studies and multiple sclerosis: a common gene, dominantly expressed
12. Twin study of multiple sclerosis: an epidemiologic inquiry
13. Multiple sclerosis in twins
14. A population-based study of multiple sclerosis in twins
15. Multiple sclerosis in a nationwide series of twins
16. Experimental autoimmune demyelination: chronic relapsing models and their therapeutic implications for multiple sclerosis
17. Experimental allergic encephalomyelitis and experimental allergic neuritis
18. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice
19. Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice
20. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis
21. Immunoregulatory T cells in multiple sclerosis: markers and functions
22. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease
23. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period
24. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis
25. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
26. CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets
27. Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis
28. Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations
29. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis: analysis with anti-2H4 monoclonal antibody
30. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity
31. Multiple sclerosis: relation of in vitro IgG secretion to T suppressor cell number and function
32. Abnormal regulation of IgG production in multiple sclerosis
33. Natural killer cell activity in multiple sclerosis
34. Natural killer cell activity in patients with multiple sclerosis given α interferon
35. 2-interferon on defective natural killer cell activity in multiple sclerosis
36. Measles virus nucleotide sequences: detection by hybridization in situ
37. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation
38. Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases
39. Viral and bacterial antibody responses in multiple sclerosis
40. Measles antibodies in multiple sclerosis
41. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis
42. Viral antibodies in oligoclonal and polyclonal IgG synthesized within the central nervous system over the course of mumps meningitis
43. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
44. Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody
45. Longitudinal analysis of three intrathecally produced immunoglobulin subpopulations in an MS patient
46. Experimental models of virus-induced demyelination of the central nervous system
47. Experimental canine distemper virus-induced demyelination
48. Pathogenesis of lentivirus infections
49. Mechanism of demyelination in JHM virus encephalomyelitis: electron microscopic studies
50. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis
51. Virus-associated demyelination: a model using avirulent Semliki Forest virus infection of mice
52. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination
53. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus
54. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis
55. Immune-mediated injury of virus-infected oligodendrocytes: a model of multiple sclerosis
56. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells
57. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases
58. Multiple sclerosis and human T-cell lymphotropic retroviruses
59. Lack of evidence for involvement of known human retroviruses in multiple sclerosis (letter to the editor)
60. Analysis of human T-lymphotropic virus sequences in multiple sclerosis tissue (letter to the editor)
61. Sera from patients with multiple sclerosis react with human T cell lymphotropic virus-I gag proteins but not env proteins—Western blotting analysis
62. Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients
63. Relevance of experimental allergic encephalomyelitis to multiple sclerosis
64. Presentation of myelin basic protein by murine cerebral vascular endothelial cells
65. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain
66. Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction
67. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination
68. Evidence for a “dying-back” gliopathy in demyelinating disease
69. Virus-induced demyelination in mice: “dying back” of oligodendrocytes